PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One pill to rule them all? new combo therapy for PAH shows promise
Disease control CompletedThis study tested whether a single pill containing two drugs (macitentan and tadalafil) works better than taking either drug alone for people with pulmonary arterial hypertension (PAH), a serious lung condition. 187 adults with PAH took either the combination pill or one of the s…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could slow breathing help PAH patients breathe easier?
Symptom relief CompletedThis study tested whether slow-paced breathing at home can help people with pulmonary arterial hypertension (PAH) manage symptoms like shortness of breath, fatigue, and poor sleep. Forty-two adults with stable PAH took part, with one group adding slow breathing exercises to their…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New ultrasound score may sharpen risk prediction for PAH patients
Knowledge-focused CompletedThis completed study looked at whether a new ultrasound score called VExUS can help doctors better assess risk in people with pulmonary arterial hypertension (PAH). Researchers measured VExUS in 86 adults and compared it to standard tests like heart catheterization and blood mark…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC